Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |